|
|
||||||||
From the Department of Epidemiology and Biostatistics (T. den Heijer, and Drs. van Duijn, Hofman, and Breteler), Erasmus Medical Center, Rotterdam; Department of Radiology (Dr. Oudkerk), Academic Hospital Groningen, the Netherlands; and National Institute on Aging (Dr. Launer), NIH, Bethesda, MD.
Address correspondence and reprint requests to Dr. M.M.B. Breteler, Department of Epidemiology & Biostatistics, Erasmus Medical Center, PO Box 1738, 3000 DR, Rotterdam, the Netherlands; e-mail: breteler{at}epib.fgg.eur.nl
The
4 allele of the APOE gene increases the risk for AD, whereas the
2 allele may be protective. The authors assessed the impact of APOE genotype on hippocampal, amygdalar, and global brain atrophy as putative markers of preclinical AD in a nondemented population. Carriers of
4 had significantly more hippocampal and amygdalar atrophy than
3
3 subjects, but not more global brain atrophy. Carriers of
2 did not have less brain atrophy than
3
3 subjects.
This article has been cited by other articles:
![]() |
S. M. Nestor, R. Rupsingh, M. Borrie, M. Smith, V. Accomazzi, J. L. Wells, J. Fogarty, R. Bartha, and the Alzheimer's Disease Neuroimaging Initiative Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database Brain, September 1, 2008; 131(9): 2443 - 2454. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Sundermann, P. E. Gilbert, and C. Murphy Apolipoprotein E {varepsilon}4 Genotype and Gender: Effects on Memory Am J Geriatr Psychiatry, October 1, 2007; 15(10): 869 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Wishart, A. J. Saykin, T. W. McAllister, L. A. Rabin, B. C. McDonald, L. A. Flashman, R. M. Roth, A. C. Mamourian, G. J. Tsongalis, and C. H. Rhodes Regional brain atrophy in cognitively intact adults with a single APOE {varepsilon}4 allele. Neurology, October 10, 2006; 67(7): 1221 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Isoniemi, T. Kurki, O. Tenovuo, V. Kairisto, and R. Portin Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injury. Neurology, September 12, 2006; 67(5): 756 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lind, J. Persson, M. Ingvar, A. Larsson, M. Cruts, C. Van Broeckhoven, R. Adolfsson, L. Backman, L.-G. Nilsson, K. M. Petersson, et al. Reduced functional brain activity response in cognitively intact apolipoprotein E {varepsilon}4 carriers Brain, May 1, 2006; 129(5): 1240 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Prins, E. J. van Dijk, T. den Heijer, S. E. Vermeer, J. Jolles, P. J. Koudstaal, A. Hofman, and M. M. B. Breteler Cerebral small-vessel disease and decline in information processing speed, executive function and memory Brain, September 1, 2005; 128(9): 2034 - 2041. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fleisher, M. Grundman, C. R. Jack Jr, R. C. Petersen, C. Taylor, H. T. Kim, D. H. B. Schiller, V. Bagwell, D. Sencakova, M. F. Weiner, et al. Sex, Apolipoprotein E {varepsilon}4 Status, and Hippocampal Volume in Mild Cognitive Impairment Arch Neurol, June 1, 2005; 62(6): 953 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pomara, L. Willoughby, K. Wesnes, D. J. Greenblatt, and J. J. Sidtis Apolipoprotein E {varepsilon}4 Allele and Lorazepam Effects on Memory in High-Functioning Older Adults Arch Gen Psychiatry, February 1, 2005; 62(2): 209 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Farlow, Y. He, S. Tekin, J. Xu, R. Lane, and H. C. Charles Impact of APOE in mild cognitive impairment Neurology, November 23, 2004; 63(10): 1898 - 1901. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. den Heijer, S. E Vermeer, E. J van Dijk, N. D Prins, P. J Koudstaal, C. M van Duijn, A. Hofman, and M. M. Breteler Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia Am. J. Clinical Nutrition, October 1, 2004; 80(4): 992 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G Manton, X. Gu, H. Huang, and M. Kovtun Fuzzy set analyses of genetic determinants of health and disability status Statistical Methods in Medical Research, October 1, 2004; 13(5): 395 - 408. [Abstract] [PDF] |
||||
![]() |
S Artero, H Tiemeier, N D Prins, R Sabatier, M M B Breteler, and K Ritchie Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1304 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. De Stefano, M. L. Bartolozzi, B. Nacmias, V. Zipoli, M. Mortilla, L. Guidi, G. Siracusa, S. Sorbi, A. Federico, and M. P. Amato Influence of Apolipoprotein E {epsilon}4 Genotype on Brain Tissue Integrity in Relapsing-Remitting Multiple Sclerosis Arch Neurol, April 1, 2004; 61(4): 536 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B Patten, S. Fridhandler, C. A Beck, and L. M Metz Depressive symptoms in a treated multiple sclerosis cohort Multiple Sclerosis, December 1, 2003; 9(6): 616 - 620. [Abstract] [PDF] |
||||
![]() |
S. E. Vermeer, N. D. Prins, T. den Heijer, A. Hofman, P. J. Koudstaal, and M. M.B. Breteler Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline N. Engl. J. Med., March 27, 2003; 348(13): 1215 - 1222. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |